SMN2 and proximal spinal muscular atrophy: Although prior studies (e.g. [9], [20], [21]) have suggested that therapeutic interventions with very modest effects in raising SMN could potentially mitigate motor neuron-autonomous phenotypes in SMA patients, our results are the first to reach that conclusion directly based on an approach to selectively raise SMN levels in motor neurons.